Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-28

Clinical Trial Update: Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0 [NA]

View source ↗

Summary

A clinical trial evaluating fetal repair of myelomeningocele in pregnancies with maternal body mass index between 35 and 40 was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Louis University | Conditions: Myelomeningocele, Pregnancy | NA | Status: TERMINATED